Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Use of Disease-Modifying Therapies in Pediatric MS.
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Selective hair cell ablation and noise exposure lead to different patterns of changes in the cochlea and the cochlear nucleus.
Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
Autoimmune Myopathies: Where Do We Stand?
Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.
Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
Unilateral olfactory sensitivity in multiple sclerosis.
Effects of Inflammasome Activation on Secretion of Inflammatory Cytokines and Vascular Endothelial Growth Factor by Retinal Pigment Epithelial Cells.
Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.
Leukodystrophies.
The change in the sex ratio in multiple sclerosis is driven by birth cohort effects.
Restriction spectrum imaging reveals decreased neurite density in patients with temporal lobe epilepsy.
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.
14-3-3 proteins regulate K2P 5.1 surface expression on T lymphocytes.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Polygenic control of autoimmune peripheral nerve inflammation in rat.
The 'best' basic science paper on multiple sclerosis in 2012.
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
First use of alemtuzumab in balo concentric sclerosis: a case report.

Pages